TRAW
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Traws Pharma filed IND for tivoxavir marboxil and updated ratutrelvir COVID-19 study resultsJan 13, 2026
- Traws Pharma doses first patient with Ratutrelvir in Phase 2 COVID studies, expects results by year-end 2025Oct 14, 2025
- Traws Pharma receives approval to proceed with Phase 2 COVID studies with Ratutrelvir, expects results by year-end 2025Aug 18, 2025
- Traws Pharma receives FDA guidance on Tivoxavir Marboxil and outlines plans for pandemic preparedness stockpilingMay 27, 2025